• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
      • Open API
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
        • AI Mission Austria
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Cellular function and degradation mechanisms of TRIM52

Gijsbert Adriaan Versteeg (ORCID: 0000-0002-6150-2165)
  • Grant DOI 10.55776/P36572
  • Funding program Principal Investigator Projects
  • Status ended
  • Start January 15, 2023
  • End January 14, 2026
  • Funding amount € 368,807
  • Project website

Disciplines

Biology (50%); Medical-Theoretical Sciences, Pharmacy (50%)

Keywords

  • Ubiquitin,
  • E3 ligase,
  • Proteasome,
  • Tripartite Motif Protein,
  • TRIM52
Abstract Final report

Through evolution, humans and other higher primates have gained means to support their increasingly complex bodies. An important aspect of this is to protect their genetic material from damage during cell duplication. Full elucidation of the human genetic code, has allowed scientists to identify factors that have been developing rapidly in human evolution, and as such may have important functions in regulating human-specific functions. One of these rapidly evolving factors is named TRIM52. We discovered that TRIM52 makes sure that human genetic material -DNA- is replicated correctly, and that cells in which TRIM52 is experimentally removed, can no longer multiply correctly. Interestingly, we found that while cells constantly produce TRIM52, it gets almost immediately degraded. This has raised the question as to why cells spend a lot of energy producing something that gets almost immediately degraded. This project aims to identify the specific cellular pathways that help replicate our DNA, that are controlled by TRIM52, and how. Moreover, the project aims to elucidate how cells rapidly degrade TRIM52, and why this is important for its cellular function. In the long term, results from this s tudy will contribute to our understanding of the strategies that have evolved in humans to support our complex bodies, systems that prevent damage to our genetic material, and consequently prevent cancer.

A human-specific protein guards our DNA, and cells destroy it almost as fast as they make it. Every cell contains thousands of proteins, each with a specific job. To stay healthy, cells carefully control protein levels by tagging surplus proteins with a molecular label called ubiquitin, sending them to the proteasome - a cellular recycling machine - for destruction. When this system fails, diseases including cancer can result. Our research focused on a protein called TRIM52, which presented two puzzles from the start. The first is evolutionary: TRIM52 is present in humans and other primates, where it has been actively shaped by natural selection, but has been lost in many other mammals. Proteins not conserved across species are typically specialized or dispensable. The second puzzle is stability: TRIM52 is destroyed so rapidly - half-life of just three to four minutes - that it is one of the most unstable proteins in the human body. Both puzzles deepened when we discovered TRIM52's function. Rather than playing a niche role, it is involved in protecting our DNA. When cells copy their DNA, a protein called Topoisomerase 2 helps untangle DNA strands but can become stuck, creating damage. TRIM52 helps resolve these blockages. Cells without TRIM52 accumulated more DNA damage and activated emergency signals halting cell division - a core quality control function, making it all the more striking that most other mammals appear to manage without it. Consistently, TRIM52 is elevated in several cancers, suggesting tumor cells depend on it for survival. We also identified three large enzymes - BIRC6, HUWE1, and UBR4 - that cooperate to label TRIM52 with ubiquitin and send it for recycling, and reconstructed this process step by step in a test tube with purified proteins. These findings raise a fascinating question guiding our future work: why did primates evolve a dedicated protein for a DNA quality control function that other mammals manage without? The answer may reveal something fundamental about how human cells handle DNA damage - and what that means for disease.

Research institution(s)
  • Universität Wien - 100%
Project participants
  • David Haselbach, Institut für Molekulare Pathologie - IMP , national collaboration partner
  • Tim Clausen, Institut für Molekulare Pathologie - IMP , national collaboration partner
  • Joanna Loizou, Medizinische Universität Wien , national collaboration partner
  • Thomas Decker, Universität Wien , national collaboration partner
International project participants
  • Fumiyo Ikeda, Kyushu University - Japan

Research Output

  • 28 Citations
  • 7 Publications
  • 1 Methods & Materials
  • 1 Datasets & models
  • 1 Software
Publications
  • 2025
    Title TRIM52 maintains cellular fitness and is under tight proteolytic control by multiple giant E3 ligases
    DOI 10.1038/s41467-025-59129-y
    Type Journal Article
    Author Shulkina A
    Journal Nature Communications
    Pages 3894
    Link Publication
  • 2026
    Title Guardian ubiquitin E3 ligases target cancer-associated APOBEC3 deaminases for degradation to promote human genome integrity.
    DOI 10.1038/s41467-026-68420-5
    Type Journal Article
    Author Budroni V
    Journal Nature communications
    Pages 1723
  • 2024
    Title ERH regulates type II interferon immune signaling through post-transcriptional regulation of JAK2 mRNA
    DOI 10.1101/2024.08.20.607899
    Type Preprint
    Author Soderholm A
    Pages 2024.08.20.607899
    Link Publication
  • 2024
    Title Disordered regions in the IRE1a ER lumenal domain mediate its stress-induced clustering
    DOI 10.1038/s44318-024-00207-0
    Type Journal Article
    Author Kettel P
    Journal The EMBO Journal
    Pages 4668-4698
    Link Publication
  • 2023
    Title Stress-induced clustering of the UPR sensor IRE1a is driven by disordered regions within its ER lumenal domain
    DOI 10.1101/2023.03.30.534746
    Type Preprint
    Author Kettel P
    Pages 2023.03.30.534746
    Link Publication
  • 2025
    Title Architecture of the UBR4 complex, a giant E4 ligase central to eukaryotic protein quality control
    DOI 10.1126/science.adv9309
    Type Journal Article
    Author Grabarczyk D
    Journal Science
    Pages 909-914
    Link Publication
  • 2024
    Title Guardian ubiquitin E3 ligases target cancer-associated APOBEC3 deaminases for degradation to promote human genome integrity
    DOI 10.1101/2024.04.23.590688
    Type Preprint
    Author Schwartz I
    Pages 2024.04.23.590688
    Link Publication
Methods & Materials
  • 2025 Link
    Title Cell lines for dox-inducible CRISPR-based genetic screening
    DOI 10.1038/s41467-025-59129-y
    Type Cell line
    Public Access
    Link Link
Datasets & models
  • 2024 Link
    Title Identification of sites of ubiquitination on protein TRIM52
    Type Database/Collection of data
    Public Access
    Link Link
Software
  • 2025 Link
    Title Analysis code for identifying mutational profiles in gDNA
    Link Link

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • IFG-Form
  • Acknowledgements
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF